DIVA Laboratories Ltd Total Liabilities

Latest as of March 2026: NT$447.40 Million TWD ≈ $14.10 Million USD

DIVA Laboratories Ltd total liabilities. Based on the latest financial reports, DIVA Laboratories Ltd (4153) has total liabilities worth NT$447.40 Million TWD (≈ $14.10 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check DIVA Laboratories Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of DIVA Laboratories Ltd (2017–2025)

Total liabilities of DIVA Laboratories Ltd from 2017 to 2025. This chart illustrates how DIVA Laboratories Ltd's total liabilities have evolved over time, based on quarterly financial data.

DIVA Laboratories Ltd Competitors by Total Liabilities

The table below lists competitors of DIVA Laboratories Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Seresco S.A. MC:SCO	Spain	€33.81 Million
Cassava Sciences Inc NASDAQ:SAVA	USA	$40.23 Million
Mandom Indonesia Tbk JK:TCID	Indonesia	Rp530.70 Billion
Cintac SN:CINTAC	Chile	CL$448.56 Million
Mercor S.A. WAR:MCR	Poland	zł106.46 Million
JCBNext Berhad Bhd KLSE:0058	Malaysia	RM5.14 Million
Biome Australia Ltd AU:BIO	Australia	AU$6.25 Million
Fanhua Inc. NASDAQ:AIFU	USA	$1.06 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down DIVA Laboratories Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is DIVA Laboratories Ltd's balance sheet.

Liquidity & Leverage Metrics

DIVA Laboratories Ltd Total Liabilities Ratios Explained

DIVA Laboratories Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.50	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.48	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.32	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DIVA Laboratories Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DIVA Laboratories Ltd (2017–2025)

The table below shows the annual total liabilities of DIVA Laboratories Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$324.52 Million ≈ $10.22 Million	+29.84%
2024-12-31	NT$249.94 Million ≈ $7.87 Million	+18.50%
2023-12-31	NT$210.93 Million ≈ $6.65 Million	-10.48%
2022-12-31	NT$235.62 Million ≈ $7.42 Million	+20.66%
2021-12-31	NT$195.27 Million ≈ $6.15 Million	+57.05%
2020-12-31	NT$124.34 Million ≈ $3.92 Million	-26.03%
2019-12-31	NT$168.09 Million ≈ $5.30 Million	+21.05%
2018-12-31	NT$138.87 Million ≈ $4.38 Million	-45.51%
2017-12-31	NT$254.84 Million ≈ $8.03 Million	--

About DIVA Laboratories Ltd

TWO:4153 Taiwan Diagnostics & Research

Market Cap

$58.13 Million

NT$1.85 Billion TWD

Market Cap Rank

#21131 Global

#1290 in Taiwan

Share Price

NT$31.45

Change (1 day)

+1.78%

52-Week Range

NT$29.75 - NT$36.50

All Time High

NT$76.08